171 related articles for article (PubMed ID: 20188136)
1. Hyperprolactinaemia in early psychosis-not only due to antipsychotics.
Aston J; Rechsteiner E; Bull N; Borgwardt S; Gschwandtner U; Riecher-Rössler A
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1342-4. PubMed ID: 20188136
[TBL] [Abstract][Full Text] [Related]
2. Prolactin and smoking status in antipsychotic-treated patients.
Mackin P; Waton A; Nulkar A; Watkinson HM
J Psychopharmacol; 2011 May; 25(5):698-703. PubMed ID: 20699354
[TBL] [Abstract][Full Text] [Related]
3. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
Bushe C; Yeomans D; Floyd T; Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
[TBL] [Abstract][Full Text] [Related]
4. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
Cookson J; Hodgson R; Wildgust HJ
J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis.
Riecher-Rössler A; Rybakowski JK; Pflueger MO; Beyrau R; Kahn RS; Malik P; Fleischhacker WW;
Psychol Med; 2013 Dec; 43(12):2571-82. PubMed ID: 23590895
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
Lally J; Ajnakina O; Stubbs B; Williams HR; Colizzi M; Carra E; Fraietta S; Gardner-Sood P; Greenwood KE; Atakan Z; Mondelli V; Ismail K; Howes O; Taylor DM; Smith S; Hopkins D; Murray RM; Gaughran F
Schizophr Res; 2017 Nov; 189():117-125. PubMed ID: 28755878
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
Bushe C; Shaw M
J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473
[TBL] [Abstract][Full Text] [Related]
8. A review of the association between antipsychotic use and hyperprolactinaemia.
Bushe C; Shaw M; Peveler RC
J Psychopharmacol; 2008 Mar; 22(2 Suppl):46-55. PubMed ID: 18477620
[TBL] [Abstract][Full Text] [Related]
9. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
10. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
Ittig S; Studerus E; Heitz U; Menghini-Müller S; Beck K; Egloff L; Leanza L; Andreou C; Riecher-Rössler A
Schizophr Res; 2017 Nov; 189():111-116. PubMed ID: 28214176
[TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
13. The impact of hyperprolactinaemia on sexual function in patients with psychosis.
Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):63-9. PubMed ID: 18477622
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics and hyperprolactinaemia: clinical recommendations.
Peveler RC; Branford D; Citrome L; Fitzgerald P; Harvey PW; Holt RI; Howard L; Kohen D; Jones I; O'Keane V; Pariente CM; Pendlebury J; Smith SM; Yeomans D
J Psychopharmacol; 2008 Mar; 22(2 Suppl):98-103. PubMed ID: 18477626
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
16. Detecting hyperprolactinaemia in mental health patients.
Shaw M
Nurs Times; 2005 Dec 6-12; 101(49):24-6. PubMed ID: 16372730
[TBL] [Abstract][Full Text] [Related]
17. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
19. The evolution of hyperprolactinaemia as an entity in psychiatric patients.
Kohen D; Wildgust HJ
J Psychopharmacol; 2008 Mar; 22(2 Suppl):6-11. PubMed ID: 18477616
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
Holt RI; Peveler RC
Clin Endocrinol (Oxf); 2011 Feb; 74(2):141-7. PubMed ID: 20455888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
